[Effectiveness of combined use of a lipid peroxidation inhibitor and a lymphatic drainage stimulant in intensive care of acute myocardial infarct].

The efficacy of intensive care for acute myocardial infarction making use of mannitol and vitamin E was under study. The results evidence a marked clinical effect of both the drugs. ECG demonstrates that in the majority of cases the necrotic process is arrested and no grave complications develop after such treatment, and the ECG parameters normalize.

[Stimulation of the lymphatic drainage in intensive care of acute myocardial infarct].

Under study was reogluman efficacy in the acute period of myocardial infarction. Timely administration of the drug to myocardial infarction patients was conductive to reduction of the duration and intensity of the painful syndrome, was associated with a reduction and even disappearance of congestion in the lungs within the first 2 days. These changes were paralleled by a more rapid normalization of the activities of all the blood serum lysosomal enzymes in the patients treated with reogluman as against the reference patients.

[Use of rheogluman in the acute period of myocardial infarction].

The efficacy of rheogluman was evaluated in 55 patients with acute myocardial infarction. ECG mapping recordings in 35 leads showed that an earlier positive dynamics in sigma ST, sigma Q, and sigma R was significantly observed in patients treated with rheogluman than in untreated patients. These data indirectly indicated a reduction in the ++peri-infarct zone in the acute period of myocardial infarction.

[The efficacy of the combined use of a lipid peroxidation inhibitor and a stimulator of the lymphatic drainage of the heart in the treatment of the acute period of myocardial infarction].

The effect of combined use of mannitol and alpha-tocopherol on the course and outcome of acute myocardial infarction has been studied. The results have shown that these drugs have a marked clinical effect. The ECG findings show that in the majority of cases the drugs prevented further development of necrotic process and the onset of life-threatening complications and accelerated normalization of the ECG parameters.

[Effect of lymph-stimulating drugs on the clinical manifestations and parameters of lipid metabolism in patients with post-infarction cardiosclerosis and angina pectoris].

As many as 64 patients with coronary heart disease (CHD) were examined. They were divided into 3 groups: (1) control subjects; (2) patients on supplementary rheogluman and (3) those on supplementary haemodesum (neocompensan). Their status was assessed from the frequency and intensity of anginal attacks, the magnitude of changes in lipid metabolic parameters prior to and following the therapy.